Background
Hematopoiesis involves the generation of pluripotent hematopoietic stem cells (HSCs) and their subsequent restriction and differentiation along one of at least seven distinct lineages. Hematopoiesis begins in two sites of the early embryo: the blood islands of the yolk sac and the splanchnopleural mesoderm that becomes the aorta-gonad-mesonephros (AGM) region [1, 2] . By late gestation, the fetal liver becomes the major site of hematopoiesis. After birth, HSCs are found in the bone marrow where they undergo self-renewal and replenish the various lineages throughout adult life. At this site, the fate of the HSC is controlled by environmental cues that ultimately signal to transcription factors that are pivotal for lineage decisions [3, 4] .
Among the lineage-determining transcription factors, Ikaros is required for the normal development and homeostasis of the lymphoid system [5] [6] [7] [8] [9] . Ikaros mRNA is detected in the earliest defined HSC progenitor and continues to be expressed throughout the development of the lymphoid lineages [5, 10, 11] . The Ikaros gene is alternatively spliced and the resulting mRNA species produce at least six distinct isoforms containing between one and four amino-terminal Krüppel-type zinc fingers which dictate the sequence specificity and DNA-binding affinity of the isoforms [12, 13] . All of the Ikaros isoforms have two Krüppel-like zinc fingers at their carboxyl termini which mediate protein dimerization [14] . Formation of homodimers and heterodimers between the DNA-binding Ikaros isoforms -Ik-1, Ik-2 and Ik-3 -dramatically increases both their affinity for DNA and their ability to activate transcription from their cognate DNAbinding sites. An Ikaros heterodimer in which one of the monomers lacks a DNA-binding domain cannot bind DNA, however, and is therefore transcriptionally inert.
The importance of Ikaros in the ontogeny and homeostasis of the immune system has been demonstrated through the analysis of two different targeted mutations in the Ikaros gene [6, 9] . Mice homozygous for a functionally null mutation in the Ikaros gene, which results in the deletion of the dimerization domain and destabilization of the
Results

Identification of Helios, a novel Ikaros-related gene
Degenerate primers encoding conserved sequences in the Ikaros amino-terminal (Ik-F) and carboxy-terminal zincfinger (Ik-R) domains [17] were used to amplify cDNAs generated from the spleen of Aiolos null mutant mice ( Figure 1 ). The strong conservation of the amino-terminal zinc-finger motifs encoded by Hel-1 and Hel-2 with those of the Ikaros isoforms Ik-1 and Ik-2 predicts that they will display similar DNA-binding properties [12] .
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Expression of Helios during embryogenesis
The expression of Helios during mouse embryogenesis was compared with Ikaros by in situ hybridization to adjacent (h,i) At day 13, Helios is detected in bright spots within the liver, whereas Ikaros is expressed at higher levels throughout the liver.
Helios is expressed in bright spots within the thymus (Th) at E16 (k) and appears highest in spots near the center of the thymus, while Ikaros is expressed at high levels throughout the thymus (l). Helios is also detected in the epithelial linings of the oesophagus (Oe) and trachea (Tr); CA represents the carotid artery. In addition to expression in the thymus, Helios can be detected in a number of epithelial tissues of the day 17 embryo (n), but is no longer detected in the liver at this stage (lower right). These include epithelial tissue in the lung (Lu), mouth, salivary glands (S) and ducts (D), tooth bud epithelium (I represents incisor), olfactory epithelium and skin. Some expression of Helios in the brain can also be seen.
expression is maintained in the postnatal thymus. Helios is also detected in a very small subset of cells within the spleen of the adult (data not shown).
Outside of the hematopoietic system, Helios expression is high in a number of epithelial tissues. These include the endoderm lining the gut, the tubules of the kidney, the lining of the respiratory tract and the olfactory epithelium. During late-gestation, high levels of Helios expression can be detected in the salivary glands and ducts (Figure 2m,n; T.I. and B.A.M., unpublished observations). In adult tissues, Helios was detected in the thymus by northern blot analysis. Although Helios is expressed in the lung, liver, kidney and brain at various times during embryogenesis, it is not detected by northern analysis in these tissues in the adult (data not shown).
Expression of Helios in hematopoietic subpopulations
The expression of Ikaros gene family members in sorted hematopoietic and lymphoid progenitors of the adult was examined by reverse transcription (RT)-PCR. Helios mRNA is detected in the bone-marrow progenitor population that is highly enriched for stem cell activity (c-Kit + Sca-1 + lineage -) and is also present in hematopoietic progenitors that have a more restricted lymphoid or erythromyeloid potential, c-Kit + Sca-1 + Sca-2 + and c-Kit + Sca-1 -Sca-2 -respectively [15, 16, 18, 19] (Figure 3a) . Ikaros displays a similar pattern of expression in these hematopoietic progenitor populations whereas Aiolos is detected only in the progenitors that are more committed to lymphoid development, c-Kit + Sca-1 + Sca-2 + ([10]; Figure 3a) . Helios is not expressed in definitive erythroid precursors (Ter119 + ) and very low levels of Helios mRNA are present within the monocyte (Mac1 + GR -) and granulocyte (Mac1 + GR + ) populations of the adult bone marrow (Figure 3c ). Ikaros is detected at low levels in all three of these cell types. Helios is present at low levels in pro-B cells (CD45R + CD43 + from Rag -/-bone marrow) and decreases as they progress to pre-B cells (CD45R + IgM + ). In contrast, Aiolos expression is low in pro-B cells and dramatically increases in pre-B and mature B cells.
As HSCs differentiate along the myeloerythroid and B lymphoid lineages, Helios expression is diminished. Helios is present at varying levels in all T cell subsets analyzed, however (Figure 3b,c) . The earliest lymphoid progenitors entering the thymus are CD4 lo (and c-Kit + ) and are not necessarily committed to the T cell lineage [20] . Helios and Ikaros are both detected in these earliest lymphoid progenitors. Among the progenitors that are CD4 -CD8 -, an increase in Helios expression is apparent during the progressive transition to the c-Kit + CD25 + and then to the c-Kit -CD25 + population [21] , in which Aiolos is first detected (Figure 3b) . A marked increase in Aiolos levels is observed at the next stage of thymocte development (c-Kit -CD25 -), whereas Helios expression decreases. Ikaros levels remain constant during these early stages of T cell differentiation. In Rag -/-mice, all thymocytes are CD4 -CD8 -and the majority of these are c-Kit + CD25 + [21, 22] due to a block to thymocyte development at this stage, whereas in a wild-type thymus the majority of cells are at the double-positive CD4 + CD8 + stage of development [23] (Figure 3b) . Helios mRNA increases as thymocytes progress from the CD4 -CD8 -double-negative to the CD4 + CD8 + double-positive stage and declines as these become single-positive (CD4 + or CD8 + ) thymocytes (Figure 3c ). Peripheral T cells have a lower expression of Helios than immature thymocytes, with the highest levels detected in γδ T cells of the skin (Vγ3) and the gut (IEL; Figure 3c ) [25, 26] . Ikaros and Aiolos are present in these T The differential patterns of expression of these three factors within the hematopoietic system might underscore their specific regulatory roles during differentiation.
Helios forms homodimers and heterodimerizes with Ikaros and Aiolos
The carboxy-terminal zinc fingers of Ikaros and Aiolos, which mediate their homodimerization and heterodimerization, are highly conserved in Helios [10, 14] . Helios-specific polyclonal antibodies recognize two Helios isoforms in thymocyte nuclear extracts from wild-type, Ikaros null and Ikaros DN +/-mice ( Figure 4a ). The Helios isoforms detected in thymocytes are approximately 64 kDa and 68 kDa, and co-migrate with the proteins produced by the Hel-1 and Hel-2 cDNAs co-expressed after transfection into the epithelial cell line 293T (Figure 4b, lanes 1,2) .
In cell lysates from the thymuses of mice expressing an epitope-tagged Ikaros DN isoform, FLAG-Ik-7, both Helios isoforms were found in complexes immunoprecipitated with a mouse monoclonal antibody to the FLAG epitope ( Figure 4b, lane 3) . Thus, Ikaros DN forms a stable complex with Helios protein isoforms and might interfere with their normal activity in vivo. Helios also forms complexes with itself, Aiolos or Ikaros when these proteins are co-transfected into 293T cells in paired combinations (Figure 4c ). Either FLAG-Hel-1 or FLAG-Hel-2 co-precipitate with Ik-1 ( Figure 4c , lanes 2,4) and both Helios isoforms also dimerize with Aiolos ( Figure 4c , lanes 6,7). IkM1 contains two point mutations in the carboxy-terminal zinc fingers of Ikaros that disrupt its ability to dimerize [14] . In contrast to Ik-1, this dimerization-deficient form of Ikaros was unable to interact with either Helios isoform ( Figure 4c, lanes 3,5) . Thus, the carboxy-terminal zinc fingers in Helios, Ikaros and Aiolos are functionally conserved and mediate the stable interactions between these proteins which might be critical for hematopoiesis as well as lymphocyte differentiation and function.
Helios is part of a higher order nuclear structure that contains Ikaros and Aiolos
Ikaros and Aiolos are part of a higher order structure in resting lymphocytes that undergoes dramatic changes upon activation (N.A. and K.G., unpublished observations and J.H. Wang, et al., unpublished observations). Helios also participates in these nuclear macromolecular structures in primary lymphoid cells. In contrast to Ikaros and Aiolos, bright staining for Helios is detected only in a small number of either resting or activated thymocytes (approximately 1 in 25 cells). In resting cells, Helios is detected in a punctate pattern within the nucleus, similar to that previously described for Ikaros and Aiolos [10, 12, 14] ( Figure 5a ). Upon thymocyte activation, Helios is redistributed into ring-like structures in the nucleus (Figure 5c ), as are Ikaros and Aiolos. Helios is also detected in a very small number of splenocytes. These cells are probably T or NK cells, as RT-PCR analysis indicated that Helios is not expressed at significant levels in myeloid, erythroid or mature B cells. Most cells in the spleen express Aiolos, but only a small subset of splenocytes also express Helios (Figure 5e-g ). In most cases, there is complete overlap in the expression of these two proteins in a punctate pattern within the nucleus. There are a few small spots where either Helios or Aiolos is detected alone, however. In addition, a few cells were observed that showed bright staining for Helios, but only faint staining for Aiolos (data not shown). Cells stained for Ikaros and Helios showed a similar co-localization of the proteins (data not shown). In T cells from the spleen of mice expressing the FLAG-Ik-7 transgene, the endogenous Helios and Aiolos proteins co-localize with Ik-7 in nuclear structures (Figure 5i-l) .
These studies establish the presence of all three family members in the same structures within the nucleus and demonstrate that Ikaros DN has the potential to interfere with the activity of the endogenous Helios and Aiolos proteins by co-localization within the same nuclear complexes. As inferred from the expression profiles of sorted cells, this immunofluorescence data also confirms the coexpression of different Ikaros family proteins in varying combinations within cells of distinct sub-populations in the thymus and spleen.
Helios can function as transcriptional activator
Helios protein contains a domain that is similar to the transcriptional activation domain of Ikaros and Aiolos. Given the near identity in the DNA-binding domain between Helios and Ikaros, we tested the ability of Helios to activate transcription from Ikaros-binding sites. The expression of a reporter gene under the control of four high-affinity Ikaros-binding sites (IkBS2) was tested in the presence of Helios or Ikaros in NIH3T3 cells [12] . A fivefold increase in reporter gene expression was detected in the presence of Helios, and a ninefold increase was detected in the presence of Ikaros (data not shown). These results confirm the functional conservation of both the DNA-binding and transcriptional activation domains in Ikaros family members.
Discussion
In the present study, we describe the identification and characterization of Helios, a new member of the Ikaros gene family. The proteins encoded by all three genes in this family have similar properties mediated by conserved functional domains. All three members bind to the consensus DNA-binding sites characterized for Ikaros and activate transcription from an adjacent promoter in cotransfection assays. Like Aiolos and Ikaros, Helios can dimerize with itself as well as with other family members including a dominant-negative version of Ikaros. Although the conservation of these domains emphasizes the similarity of these proteins, other regions differ between the proteins encoded by these genes and might confer functional specificity among them. The functional significance of these genes is supported by the fact that the regions that diverge between family members are conserved in the orthologs of these genes in other species. Ikaros orthologs have been reported in the chicken, frog and fish and their identity is confirmed by our analysis of Aiolos and Helios orthologs in these species as well ( [26, 27] ; T.I. and B.A.M., unpublished observations). This analysis has also revealed that the previously reported partial 'Ikarosrelated gene' [17] is the Xenopus homolog of Helios. The divergent regions include domains that interact with other proteins which might therefore mediate this functional specificity (J.K. and K.G., unpublished observations).
The importance of Ikaros and Aiolos in hematopoietic development has been established by mutational analysis ( [6, 8, 9, 28] ; J.H. Wang, et al., unpublished observations). Ikaros and Aiolos are co-expressed at varying levels in most branches of this lineage and co-localize in macromolecular nuclear complexes ( [10] ; J.H. Wang, et al., unpublished observations). Recent co-localization studies suggest that these macromolecular complexes sequester lineage-specific genes in a repressed state that might be reversed during lineage progression [29] . Although the activation of these genes may then require dissolution of these macromolecular complexes, it is likely that Ikaros and Aiolos contribute directly to the transcriptional activation of lineage-specific genes as well, albeit in a different macromolecular context ( [5, 30] ; A. Nichogiannopoulou and K.G., unpublished observations). These observations have led to the model proposing that varying levels of Ikaros and Aiolos expression in the cell lead to distinct combinations of heteromeric and homomeric complexes between these proteins; the functional differences between these complexes contribute to changes in gene expression as the lymphoid lineages progress. Consistent with this model, Aiolos is expressed at higher levels than One prediction resulting from analysis of Ikaros DN mice was that another member of the Ikaros gene family would co-operate with Ikaros in the earliest stages of the hematopoietic lineage when Aiolos is not expressed. The expression of Helios at sites where HSCs arise suggests that this gene is an important regulator of the earlier stages of hematopoietic development. Hematopoietic progenitors accumulate in the yolk sac at embryonic day 8 and the fetal liver at embryonic day 11. Both Ikaros and Helios are expressed in moderate numbers of cells in these regions at early stages, although Ikaros expression is consistently greater than that of Helios. As gestation continues, these sites are increasingly populated by more committed erythroid progenitors. Whereas Ikaros expression increases dramatically in both sites, Helios remains expressed in a limited number of cells. This may reflect its preferential expression in the less-committed hematopoietic progenitors.
The expression of Helios in sorted hematopoietic cells in the adult supports this interpretation. Helios is expressed in adult HSCs but its expression decreases in the maturing erythroid, macrophage and B cell lineages. Helios expression peaks in the early stages of T cell development and decreases as T cells mature in the thymus and are exported to the periphery. Significant levels of Helios are maintained in only a small subset of mature T cells. Upon immunization, Helios is detected in a very small number of cells in germinal centers of the spleen that might be T helper cells (data not shown). When compared with that of Ikaros and Aiolos, this profile of Helios expression suggests that transcriptional complexes including Ikaros and Helios will predominate in the earlier stages of hematopoiesis. This combination may be important for the self-renewing capacity of early progenitors that is compromised in the Ikaros DN -/-mice (A. Nichogiannopoulou and K.G., unpublished observations). The increasing expression of Aiolos and Ikaros as development proceeds may lead to complexes that promote lineage progression and differentiation.
Whereas Ikaros and Aiolos are predominantly expressed in hematopoietic sites, Helios is also expressed elsewhere in the embryo. Although a more detailed analysis of this expression pattern is required, it is tempting to speculate that the Ikaros gene family regulates lineage progression in other tissues as well. The dynamic expression of Helios in the embryo is consistent with such a role. Mutational analysis of the Helios gene will help to dissect its role in regulating progenitor development in the hematopoietic system and elsewhere in the embryo.
Materials and methods
Cloning of the Helios gene
A 980 bp Helios fragment was obtained from cDNA from the spleen of an Aiolos -/-mouse (J.H. Wang, et al., unpublished observations) by PCR using degenerate oligos encoding the GEKPFK and YTIHMG motifs (single-letter amino-acid code) as previously described [17] . The RACE-PCR technique (Marathon cDNA Amplification Kit; Clontech) was used to obtain a full-length clone. PCR analysis of Helios expression in hematopoietic cells using various combinations of specific 5′ and 3′ primer pairs routinely yielded two bands (corresponding to Hel-1 and Hel-2). These two bands were cloned and sequenced to show that the two alternatively spliced transcripts differ in the presence of sequence encoding the first amino-terminal zinc finger.
Expression analysis
See supplementary materials for full details of PCR conditions, primers, and isolation of hematopoietic cell populations. In situ analysis was carried out essentially as described [31] with single-stranded [ 33 P]UTP-labeled antisense RNA probes. Slides were exposed for 5 weeks.
Preparation of a Helios-specific polyclonal antibody and western blot analysis
A Helios peptide from amino acids 223-459 (Figure 1 ) was generated using the Xpress system (Invitrogen). Rabbit polyclonal antibodies raised to this protein were affinity-purified by pH elution [32] . Specificity of this antibody for Helios and not other Ikaros homologs was confirmed by western blot analysis of protein extracts from transfected 293T cells (see below) and by immunofluorescence of transfected cells (data not shown).
Thymic nuclear extracts were prepared as previously described [14] . Protein lysates were resolved on a 10% SDS-PAGE gel, transferred to an Immobilon-P membrane (Millipore) and probed with the affinity-purified polyclonal Helios antibodies (1:500 dilution in PBS/0.05% TWEEN-20). To detect Helios in primary cells, the signal was amplified by incubation of the filter with a 1:5 000 dilution of biotinylated goat anti-rabbit antibody followed by the same dilution of peroxidase-coupled streptavidin (Jackson Labs). The ECL kit (Amersham) was used for detection.
Expression constructs and transfection of 293T cells
The full-length Hel-1 or Hel-2 isoforms were cloned into CDM8, creating CDM8-Hel-1 and CDM8-Hel-2. Additional constructs were generated containing the FLAG or hemagglutinin (HA) tags (FLAG-Hel-1, FLAG-Hel-2, HA-Hel-1, HA-Hel-2). Transfections of 293T cells and immunoprecipitations were performed as described [14] . Western blot analysis was as described above except that, for 293T extracts, incubation with affinity-purified polyclonal antibodies specific for Ikaros [12] , Aiolos [10] or Helios was followed by incubation with peroxidasecoupled goat anti-rabbit secondary antibody. For immunoprecipitation from primary cells, thymocytes or splenocytes were obtained from transgenic mice expressing the FLAG-tagged dominant-negative version of Ikaros, Ik-7, from the CD2 minigene [33] . Cells were harvested, washed in PBS/2% FCS, and lysed in 100 µl lysis buffer as described [14] .
Confocal immunofluorescence
Primary thymocytes or splenocytes were obtained as previously described [6] . Thymocytes were activated for 40 h as described [8] . Cells were harvested, cytospun onto slides and fixed in 4% paraformaldehyde.
Supplementary material
A detailed methodological section is published with this paper on the internet.
